General Information of the Compound
| Compound ID |
CP0520000
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-(piperazin-1-yl)-3-tosyl-1H-indazole
Show/Hide
|
||||||||||||||||||
| Synonyms |
4-(piperazin-1-yl)-3-tosyl-1H-indazole
CHEMBL1277834
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C18H20N4O2S
|
||||||||||||||||||
| Molecular Weight |
356.451
|
||||||||||||||||||
| Canonical SMILES |
Cc1ccc(cc1)S(=O)(=O)c1n[nH]c2cccc(N3CCNCC3)c12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C18H20N4O2S/c1-13-5-7-14(8-6-13)25(23,24)18-17-15(20-21-18)3-2-4-16(17)22-11-9-19-10-12-22/h2-8,19H,9-12H2,1H3,(H,20,21)
Show/Hide
|
||||||||||||||||||
| InChIKey |
SJAUEJQIVFASOP-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound